The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Krasheninnikov A.A.

FGBU «Moskovskiĭ nauchno-issledovatelskiĭ onkologicheskiĭ institut im. P.A. Gertsena» Minzdrava Rossii

Niushko K.M.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Safronova E.Yu.

P.A. Herzen Moscow Oncology Research Institute, Branch, National Medical Radiology Research Center, Ministry of Health of Russia, Moscow, Russia

Kalpinskiĭ A.S.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossiii

Kostin A.A.

Herzen Moscow Oncology Research Institute of Healthcare Ministry of the Russian Federation — branch of National Medical Research Radiology Center

Kaprin A.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Drug therapy methods in patients with metastatic castration-resistant prostate cancer: Role of somatostatin analogues

Authors:

Krasheninnikov A.A., Niushko K.M., Safronova E.Yu., Kalpinskiĭ A.S., Kostin A.A., Kaprin A.D.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2017;6(3): 76‑81

Read: 867 times


To cite this article:

Krasheninnikov AA, Niushko KM, Safronova EYu, Kalpinskiĭ AS, Kostin AA, Kaprin AD. Drug therapy methods in patients with metastatic castration-resistant prostate cancer: Role of somatostatin analogues. P.A. Herzen Journal of Oncology. 2017;6(3):76‑81. (In Russ.)
https://doi.org/10.17116/onkolog20176376-81

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.